Enterix Inc

Enterix, Inc. is a biotechnology company specializing in fecal immunochemical tests (FIT) for colorectal cancer screening and detection of lower gastrointestinal bleeding disorders. Founded in 1997 and based in Edison, NJ, the company emphasizes non-invasive, patient-friendly testing with simple at-home sample collection. Core products include InSure FIT (lab-based test for occult blood detection), InSure Quik FIT (point-of-care physician office version), and InSure One (at-home test using toilet bowl water collection via brush). All products support annual colorectal cancer screening recommendations aligned with American Cancer Society guidelines (screening starting at age 45). Enterix operates internationally with FDA clearance, CLIA waiver certification, and TGA licensing. Distribution partnerships include Quest Diagnostics and HemoCue, Inc., enabling availability through healthcare providers, pharmacies, and direct-to-consumer channels. The company prioritizes screening adherence through elimination of stool handling and sample preparation requirements.